Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.

Computers in biology and medicine - 1 Sept 2022

Kumar S Udhaya, Balasundaram Ambritha, Cathryn R Hephzibah, Varghese Rinku Polachirakkal, R Siva, R Gnanasambandan, Younes Salma, Zayed Hatem, Doss C George Priya

Abstract excerpt

BACKGROUND: Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC accounts for 84% of all lung cancer cases. In recent years, advances in pathway understanding, methods for discovering novel genetic biomarkers, and new drugs designed to inhibit the signaling cascades have enabled clinicians to personalize therapy for NSCLC. OBJECTIVES: The primary aim of this study is to identify the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Exome Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Forkhead Transcription Factors

Share to Lung Neoplasms

Share to Phosphatidylinositol 3-Kinases

Share to Polymorphism, Single Nucleotide

Share to Repressor Proteins

Source

Identifiers

PMID: 35753820
DOI: 10.1016/j.compbiomed.2022.105701

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.PMID 35753820Read ↗

Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencingSemantic proximity Read ↗

Identification of Molecular Biomarkers Associated with Non-Small-Cell Lung Carcinoma (NSCLC) Using Whole-Exome Sequencing AnalysisSemantic proximity Read ↗

Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.Semantic proximity Read ↗

Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations.Semantic proximity Read ↗

Analysis of Genes Involved in Lung Cancer: Study of 101 Cases Through Massive SequencingSemantic proximity Read ↗

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.Semantic proximity Read ↗

Mutation profile of non-small cell lung cancer revealed by next generation sequencing.Semantic proximity Read ↗

Synonymous Variants of Potential Significance Identified by a 52-Gene Clinical Sequencing Panel in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer.Semantic proximity Read ↗

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.Semantic proximity Read ↗

Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.Semantic proximity Read ↗

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.